CADL
Candel Therapeutics Inc
NASDAQ: CADL · HEALTHCARE · BIOTECHNOLOGY
$6.18
-0.32% today
Updated 2026-04-29
Market cap
$476.11M
P/E ratio
—
P/S ratio
436.42x
EPS (TTM)
$-0.72
Dividend yield
—
52W range
$4 – $8
Volume
1.6M
Candel Therapeutics Inc (CADL) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
+36.3%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+27.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.7%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-26 | $-0.29 | -17.0% | $4.99 | $4.81 | -3.6% |
| 2025-11-13 | $-0.21 | -16.7% | $4.92 | $4.64 | -5.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.25 | $-0.29 | -17.0% | — | — |
| 2025-09-30 | $-0.18 | $-0.21 | -16.7% | — | — |
| 2025-06-30 | $-0.16 | $-0.09 | +43.8% | — | — |
| 2025-03-31 | $-0.37 | $0.13 | +135.1% | — | — |
| 2024-12-31 | $-0.30 | $-0.40 | -33.3% | $1.00M | -43.7% |
| 2024-09-30 | — | $-0.33 | — | — | — |
| 2024-06-30 | — | $-0.74 | — | — | — |
| 2024-03-31 | $-0.28 | $-0.28 | -0.6% | $1.78M | — |
| 2023-12-31 | $-0.16 | $-0.38 | -137.5% | $1.78M | — |
| 2023-09-30 | $-0.19 | $-0.31 | -63.2% | — | — |
| 2023-06-30 | $-0.30 | $-0.34 | -13.3% | — | — |
| 2023-03-31 | $-0.35 | $-0.30 | +14.3% | — | — |
Frequently asked questions
Has Candel Therapeutics Inc beaten earnings estimates?
Candel Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of +36.3% over the last 4 quarters.
How does CADL stock react to earnings?
CADL stock has moved an average of -4.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.